Systemic Lupus Erythematosus (SLE)
Home / Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disease driven by immune complex deposition and interferon signaling. Recent advances include:
- Belimumab (Benlysta®) – B-cell survival inhibition
- Anifrolumab (Saphnelo®) – type I interferon receptor blockade
Research is now focused on organ-specific lupus (e.g., lupus nephritis) and precision
immunology.
Your Financial Contribution Can Help Us Fund Critical Programs & Initiatives
As a Nonprofit organization, we are deeply committed to raising awareness, providing patient support, and advocating for research for individuals living with various disease states.
Quick Links
Rare Diseases
Contact Us
For general questions about our organization, our mission, or how you can get involved, please email us. We endeavor to respond to all inquiries